Concepedia

Publication | Open Access

BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer

16

Citations

17

References

2022

Year

Abstract

We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.

References

YearCitations

Page 1